Results 201 to 210 of about 3,688,360 (335)
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou +5 more
wiley +1 more source
Retraction notice to "A study on participatory experiences in cultural and tourism commercial spaces" [Heliyon 10 (2024) e24632]. [PDF]
Jiang Z, Jiang X, Jin Y, Tan L.
europepmc +1 more source
News and Notices. National Prize of the Czech Socialist Republic awarded to Professor Alois Kufner [PDF]
openalex +1 more source
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source
Retraction notice to "Novel dynamic fuzzy decision-making framework for COVID-19 vaccine dose recipients" [J. Adv. Res. 37 (2022) 147-168]. [PDF]
Albahri OS +13 more
europepmc +1 more source
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan +9 more
wiley +1 more source
BIOLINGUISTICS Editorial Team
doaj +2 more sources
Retraction notice to "Molecular modeling of the structural, electronic, excited state dynamic, and the photovoltaic properties of the oligomers of n-corannulene (n = 1-4)" [Heliyon 9 (2023) e20706]. [PDF]
Hadi H +3 more
europepmc +1 more source

